Denis Corin is CEO & 10% at Q BioMed Inc. (QBIO). They have made 2 open-market trades across 2 companies since 2011, most recently 2022-05-26.
CIK 0001405626
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases since 2017, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| QBIO | SELL | 2018-07-12 | 2019-11-06 | $2.11 | $14K | N/A | N/A | N/A |
| QBIO | SELL · 10b5-1 | 2018-07-09 | 2018-07-11 | $3.11 | $44K | N/A | N/A | N/A |
| QBIO | SELL · 10b5-1 | 2018-07-05 | 2018-07-09 | $3.56 | $48K | N/A | N/A | N/A |
| QBIO | SELL · 10b5-1 | 2018-07-02 | 2018-07-03 | $3.44 | $14K | N/A | N/A | N/A |
| QBIO | SELL · 10b5-1 | 2018-06-28 | 2018-07-02 | $3.39 | $25K | N/A | N/A | N/A |
| QBIO | SELL · 10b5-1 | 2018-06-25 | 2018-06-28 | $3.43 | $35K | N/A | N/A | N/A |
| QBIO | SELL · 10b5-1 | 2018-06-21 | 2018-06-25 | $3.46 | $31K | N/A | N/A | N/A |
| TPIV | SELL | 2011-03-23 | 2011-04-05 | $0.12 | $19K | -23.4% | -3.3% | -3.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.